Recruiting

Ocular Lipid Layer

Sponsor:

Indiana University

Code:

NCT07579130

Conditions

Dry Eye

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

LipiView

Omnicad

Bruder Ocular Surface Analyzer

Study Details

Brief summary:

This study compares ocular lipid layer thickness (LLT) measurements obtained from three commonly used clinical diagnostic devices to evaluate their agreement and consistency. It further examines which device's LLT measurements show the strongest correlation with established clinical indicators of dry eye disease severity.

Conditions

Dry Eye

Study ID

NCT07579130

Start date

Apr 1, 2026

Status verified date

May, 2026

Completion date

Dec 20, 2028

Anticipated

Primary completion date

Dec 20, 2028

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • Dry eye disease

Exclusion Criteria:

  • None

Study Design

Enrollment

50 participants

Anticipated

Interventions and Outcome Measures

Arms

Dry Eye

Patients with dry eye disease will undergo measurement of lipid layer thickness on all 3 devices in random order.

Interventions

LipiView

Subjects will undergo lipid layer thickness measurement

Omnicad

Subjects will undergo lipid layer thickness measurement

Bruder Ocular Surface Analyzer

Subjects will undergo lipid layer thickness measurement

Primary outcome measure

  • Lipid Layer Thickness [ Time Frame: measurements taken at single visit, baseline ]

Central Contacts and Locations

Central contacts

Anna Tichenor

8128550520annatich@iu.edu

Locations

Atwater Eye Care Center

Recruiting

Bloomington, Indiana, United States, 47405

Contacts

Anna Tichenor

812-855-0520annatich@iu.edu

Principal Investigator:

Anna Tichenor, OD PhD

More Information

Sponsor

Indiana University

Last update posted

May 11, 2026

Last verified

May, 2026

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-09. This information was provided to ClinicalTrials.gov by Indiana University on 2026-05-11.